Sasan K. Goodarzi filed an initial statement of beneficial ownership with the SEC on November 13, 2026, disclosing his status as a newly reporting director of Marvell Technology, Inc., with a triggering event date of November 12, 2026.
Douglas R. Bettinger filed an initial statement of beneficial ownership with the SEC on November 13, 2026, disclosing his status as a newly appointed director of Marvell Technology, Inc. (NASDAQ:MRVL), with an event date of November 12, 2026.
Tri-County Financial Group, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 13, 2026, reporting third-quarter and year-to-date financial results for the Illinois-based community bank holding company.
Chaince Digital Holdings Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 13, 2026, reporting financial results for its financial services and advisory businesses.
Earnest Partners LLC filed a Schedule 13G Amendment No. 2 with the SEC on November 13, 2026, disclosing beneficial ownership of 3,033,764 shares of Ryder System Inc common stock as of September 30, 2026.
Earnest Partners LLC filed an amended Schedule 13G with the SEC on November 12, 2026, disclosing a 4.9% beneficial ownership position in Box Inc Class A Common Stock as of September 30, 2026.
First Trust Merger Arbitrage Fund, First Trust Capital Management L.P., First Trust Capital Solutions L.P., and FTCS Sub GP LLC jointly filed an amended Schedule 13G with the SEC on November 13, 2026, disclosing beneficial ownership positions in RF Acquisition Corp II as of …
Encompass Capital Advisors LLC, Encompass Capital Partners LLC, and Todd J. Kantor filed Amendment No. 7 to their Schedule 13D on November 13, 2026, disclosing a new commitment letter with T1 Energy Inc. and updated beneficial ownership figures as of November 11, 2026.
Amova Asset Management Americas, Inc. filed Amendment No. 3 to a Schedule 13G with the SEC on November 12, 2026, disclosing beneficial ownership of 1,689,107 shares of Arcturus Therapeutics Holdings Inc common stock as of September 30, 2026.
Inuvo, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 13, 2026, disclosing condensed consolidated balance sheet data and changes in its capital structure.